https://www.selleckchem.com/products/kartogenin.html patients to increase their quality of life as much as possible.Urinary tract infection (UTI) is a major clinical problem in a wide age range that is associated with a high morbidity rate. Due to issues such as low specificity and the inability to differentiate between different types of infection in current diagnostic methods, there is a need to introduce novel UTI markers. The present study was conducted to evaluate the utility of Procalcitonin (PCT) and interleukin-6 (IL-6) as a marker of bacterial urinary tract infection. For this purpose, a cross-sectional study was conducted between November 2020 and February 2021 among 125 patients and 60 healthy volunteers (control) in Erbil Teaching Hospital. The concentration of PCT and IL-6 was quantified using the ELISA cloud immunoassay test. Between-group comparisons were assessed for the variables with analysis of variance. The results revealed that there was a significant difference between PCT levels in UTI patients (104.6±6.07) and control groups (54±2.24) (p less then 0.0001). The differences in IL-6 concentration in UTI patients (55.74±4.2) and control groups (24.56±2.4) were also significant (p less then 0.0001), implying that the level of both PCT and IL-6 increased due to bacterial infection in the urinary tract. As a whole, the findings of this study provide.The objective of this research was to study the correlation between PPARγ, Aβ1-42, miR-155 and the occurrence and development of diabetes. For this purpose, 52 patients with diabetes who were hospitalized from September 2019 to May 2021 were selected as the research objects. They were grouped according to the severity of the disease, which was pre-diabetes (n=16), mild (n=25), and moderate (n=16). =11), another 20 healthy subjects were taken as the control group, and the levels of PPARγ, Aβ1-42, miR-155 in each group were measured, and the correlation between changes in the levels of various indicators a